Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study

Singh "Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)" Am J Cardiol (1999) 10.1016/s0002-9149(98)01064-9

[2]

Iung "A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease" Eur Heart J (2003) 10.1016/s0195-668x(03)00201-x

[3]

Ajmone Marsan "Valvular heart disease: shifting the focus to the myocardium" Eur Heart J (2023) 10.1093/eurheartj/ehac504

[4]

Bando "Filling the Gap between guidelines and current surgical practice: is early surgery justified in patients with asymptomatic severe aortic regurgitation with normal left ventricular function?" Semin Thorac Cardiovasc Surg (2019) 10.1053/j.semtcvs.2019.05.027

[5]

Maeda "Outcomes after aortic valve replacement for asymptomatic severe aortic regurgitation and normal ejection fraction" Semin Thorac Cardiovasc Surg (2019) 10.1053/j.semtcvs.2019.02.005

[6]

Otto "2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines" Circulation (2021)

[7]

Vahanian "2021 ESC/EACTS Guidelines for the management of valvular heart disease" Eur Heart J (2022) 10.1093/eurheartj/ehab395

[8]

Dujardin "Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study" Circulation (1999) 10.1161/01.cir.99.14.1851

[9]

Rawasia "Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: a systematic review and meta-analysis" Catheter Cardiovasc Interv (2019) 10.1002/ccd.27840

[10]

Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation

Enrico Poletti, Ole De Backer, Andrea Scotti et al.

JACC: Cardiovascular Interventions 2023 10.1016/j.jcin.2023.07.026

[11]

Zoghbi "Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance" J Am Soc Echocardiogr (2017) 10.1016/j.echo.2017.01.007

[12]

Kappetein "Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document" J Thorac Cardiovasc Surg (2013) 10.1016/j.jtcvs.2012.09.002

[13]

Katz "Progress in development of the index of ADL" Gerontologist (1970) 10.1093/geront/10.1_part_1.20

[14]

Fried "Frailty in older adults: evidence for a phenotype" J Gerontol A Biol Sci Med Sci (2001) 10.1093/gerona/56.3.m146

[15]

Baumbach "A heart valve dedicated for aortic regurgitation: review of technology and early clinical experience with the transfemoral Trilogy system" Catheter Cardiovasc Interv (2023) 10.1002/ccd.30795

[16]

Makkar "Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial" Lancet (2020) 10.1016/s0140-6736(20)31358-1

[17]

Thiele "Comparison of newer generation self-expandable vs balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial" Eur Heart J (2020) 10.1093/eurheartj/ehaa036

[18]

Feldman "Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: the REPRISE III randomized clinical trial" JAMA (2018) 10.1001/jama.2017.19132

[19]

Yoon "Transcatheter aortic valve replacement in pure native aortic valve regurgitation" J Am Coll Cardiol (2017) 10.1016/j.jacc.2017.10.006

[20]

Haddad "Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: a systematic review and meta-analysis" Clin Cardiol (2019) 10.1002/clc.23103

[21]

Sawaya "Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study" JACC Cardiovasc Interv (2017) 10.1016/j.jcin.2017.03.004

[22]

Alharbi "Transcatheter aortic valve replacement vs surgical replacement in patients with pure aortic insufficiency" Mayo Clin Proc (2020) 10.1016/j.mayocp.2020.07.030

[23]

Généreux "Staging the extent of cardiac damage among patients with valve disease: growth of evidence continues" JACC Cardiovasc Interv (2023) 10.1016/j.jcin.2022.11.004

[24]

Saint Croix "Clinical impact of preexisting right bundle branch block after transcatheter aortic valve replacement: a systematic review and meta-analysis" J Interv Cardiol (2020) 10.1155/2020/1789516

[25]

Hahn "Comprehensive echocardiographic assessment of normal transcatheter valve function" JACC Cardiovasc Imaging (2019) 10.1016/j.jcmg.2018.04.010

[26]

Vora "Progressing forward in transcatheter aortic valve replacement for pure aortic regurgitation" JACC Cardiovasc Interv (2023) 10.1016/j.jcin.2023.07.025

[27]

Kumar "Current Society of Thoracic Surgeons model reclassifies mortality risk in patients undergoing transcatheter aortic valve replacement" Circ Cardiovasc Interv (2018) 10.1161/circinterventions.118.006664

Cited By

117

2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Latha P. Palaniappan, Norrina B. Allen · 2026

Circulation

Transcatheter Aortic Valve Replacement With the Trilogy Valve for Leaflet Perforation of a Freestyle Graft

Maarten Vanhaverbeke, KARL DUJARDIN · 2025

JACC: Cardiovascular Interventions

Novel transcatheter aortic valve replacement devices

Ankur Sethi, Mark Russo · 2025

JTCVS Structural and Endovascular

2025 ESC/EACTS Guidelines for the management of valvular heart disease

Fabien Praz, Michael A Borger · 2025

European Heart Journal

Metrics

117

Citations

27

References

Details

Published: Apr 01, 2024
Vol/Issue: 403(10435)
Pages: 1451-1459
License: View

Authors

From Baylor Scott and White Health, Plano, TX (M.J.M., D.L.B.); Columbia University Irving Medical Center and New York–Presbyterian Hospital (M.B.L., S.K.K., R.T.H., M.C.A., C.R.S.) and New York University Langone Medical Center (M.R.W.) — both in New York; Medstar Heart and Vascular Institute, Georgetown University, Washington, DC (V.H.T.); Cedars–Sinai Heart Institute, Los Angeles (R.M.); Robert Wood Johnson Medical School, Rutgers University, New Brunswick (M.R.), and Gagnon Cardiovascular...

W

Wen Cheng

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California

From the Columbia University Medical Center (M.B.L., C.R.S., S.K.K., D.D., J.W.M., R.T.H., M.C.A.) and New York University Langone Medical Center (M.R.W.) — both in New York; Baylor Scott and White Healthcare, Plano, TX (M.J.M., D.L.B.); Cedars–Sinai Medical Center, Los Angeles (R.R.M., A.T.), Stanford University, Stanford (D.C.M., W.F.F.), and independent consultant (W.N.A.), Lake Forest — all in California; Cleveland Clinic, Cleveland (L.G.S., E.M.T., S.K., W.A.J.); Emory University, Atlanta (V.H.T., V...

Funding

JenaValve Technology Inc

Cite This Article

Torsten P Vahl, Vinod H Thourani, Raj R Makkar, et al. (2024). Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study. The Lancet, 403(10435), 1451-1459. https://doi.org/10.1016/s0140-6736(23)02806-4

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study

You May Also Like